Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bertolini (Orbassano, Italy), G. Ciprandi (Genova, Italy), F. Gallo (Genova, Italy), E. Riccardi (Orbassano, Italy), V. Carriero (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy). Phenotyping asthmatic outpatients by cluster analysis in a real-world setting. 3708

Member's Comments

No comment yet.

Related content which might interest you: Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Cluster analysis and clinical asthma phenotypes Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Clustering analysis for omalizumab responder patient profiles identification. Fenoma study Source: International Congress 2018 – Asthma management Year: 2018 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Data-driven questionnaire based cluster analysis of asthma in Swedish adults. Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Assessment of a responder identification treatment algorithm for omalizumab in a naturalistic setting Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Unsupervised and externally validated clinical cluster analysis from the U-BIOPRED paediatric cohorts Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Is spirometry in general practice adequately performed or not? Preliminary data of an evaluation study in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001 Muscle phenotypes in COPD patients: An exploratory cluster analysis Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Clustering of COPD patients admitted to pulmonary rehabilitation: a retrospective cohort analysis Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD Year: 2021 Differences in asthma outpatient therapy - data from the EGEA study Source: Eur Respir J 2003; 22: Suppl. 45, 296s Year: 2003 Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study Source: Eur Respir J 2006; 28: Suppl. 50, 313s Year: 2006 Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1) Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016